ABIGAIL HADDOCK: Open Payments
NPI 1518680545 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 20 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $94 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $198 |
| PFIZER INC. | 3 | $75 |
| ABBVIE INC. | 3 | $70 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Inspire Medical Systems, Inc. | 1 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $24 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Wegovy, PREVNAR 20, Ozempic, UBRELVY, CAPVAXIVE, INSPIRE, JARDIANCE, MOUNJARO.
Industry payments across MD — which companies pay providers there.
